Clinical trial
Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast…
NCT00005608 · Northwestern University, Other · Terminated
Key facts
| NCT number | NCT00005608 |
|---|---|
| Title | Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer |
| Official title | Orzel (UFT+Leucovorin) as First-Line Therapy for Metastatic Breast Cancer |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | leucovorin calcium, tegafur-uracil |
| Start date | Feb 1, 2000 |
| Primary completion | Jun 1, 2002 |
| Completion | Jun 1, 2002 |
| First posted | Apr 19, 2004 |
| Last update posted | Jun 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: